cystrin - Sökresultat

avadel legacy pharmaceuticals, llc - cysteine hydrochloride (unii: zt934n0x4w) (cysteine - unii:k848jz4886) - nouress is indicated for use as an additive to amino acids solutions to meet nutritional requirements of neonates (preterm and term infants less than one month of age) requiring total parenteral nutrition. nouress is contraindicated in: - patients with known hypersensitivity to one or more amino acids. - patients with inborn errors of amino acid metabolism due to risk of severe metabolic or neurologic complications. - patients with pulmonary edema or acidosis due to low cardiac output. risk summary nouress for use as an additive to amino acid solutions to meet nutritional requirements is not indicated for use in adults. appropriate administration of nouress is not expected to cause major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with cysteine hydrochloride. risk summary nouress is used as an additive to amino acid solutions to meet nutritional requirements of neonates requiring total parenteral nutrition and is not indicated for use i

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

cystine 500mg capsules

special order - l-cystine - oral capsule - 500mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

cystine 500mg oral powder sachets

special order - l-cystine - not applicable - 500mg